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Abstract
Background: Dietary supplements (DSs) can be purchased over-the-counter but may also be prescribed
by medical personnel for specific therapeutic reasons. Few studies have examined this latter source of DSs
despite the fact that 79% of physicians and 82% of nurses have recommended DSs to their patients. This
investigation examined demographic factors associated with temporal trends in oral DS prescriptions filled
by all United States (US) service members (SMs) from 2005 to 2013 (n = 1,427,080 ± 22,139, mean ± standard
deviation per year).
Methods: The Food and Drug Administration National Drug Code database and the formularies of the US Defense
Health Agency’s Pharmacoeconomic Center were queried to identify DSs available to SMs. The number of these DS
prescriptions filled by all SMs from 2005 through 2013 was then obtained from the US Department of Defense
Pharmacy Data Transaction System. Data were grouped by American Hospital Formulary System (AHFS)
pharmacologic-therapeutic classifications and examined over time. Denominators (number of SMs each year)
were obtained from the Defense Health Agency.
Results: Major findings included 1) generally greater prevalence of prescriptions filled by women and older SMs
for most AHFS categories; 2) a temporal decline in total prescriptions filled by Marine Corps personnel accounted
for by a decline in the prevalence of zinc preparations filled by younger male Marines; 3) a temporal decline in
the prevalence of iron preparations filled by women; 4) a temporal increase in the prevalence of prescriptions for
replacement preparations filled by women accounted for largely by more prescriptions for calcium compounds;
and 5) a temporal decline in the prevalence of prescriptions filled for cathartics/laxatives in older SMs accounted
for largely by a decline in prescriptions for sodium/potassium compounds.
Conclusions: These temporal trends may be associated with the greater health care utilization of women and
older SMs as well as the perceptions of prescribers and/or patients on appropriate roles of these substances in
medicine and public health.
Keywords: Multivitamins, Vitamins, Minerals, Iron, Zinc, Replacement preparations, Sodium/potassium
compounds, Antacids, Absorbents
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Background
Dietary supplements (DSs) are commercially available
products that are consumed as an addition to the usual
diet and include vitamins, minerals, herbs (botanicals),
amino acids and a variety of other substances [1].
Surveys of health care providers found that 79% of
physicians, 82% of nurses, and 97% of dietitians had
recommended DSs to their patients [2, 3]. Numerous
investigations have quantified the prevalence of self-
prescribed, over-the-counter DS use among civilians
[4–7] and military personnel [8–11]. However, in
addition to purchasing DSs over-the-counter, military
service members (SMs) can obtain prescriptions for
DSs from their medical care providers and fill those
prescriptions in the military health care pharmacy system.
Information on filled prescriptions is documented by the
US Department of Defense Pharmacy Data Transaction
System (PDTS) along with specific demographic informa-
tion. This provides an opportunity to examine DS pre-
scription prevalence and temporal trends in relation to
the demographic characteristics of the SM population.
A few studies have examined prescribed DS use among
civilians, but these studies are based on self-reports ra-
ther than information obtained from medical records
[12–14], and only one study [12] has examined the
demographics of users. The US Department of Defense
PDTS captures all medications dispensed at military
treatment facilities and retail pharmacies. A few previous
studies used PDTS data to examine trends in some DS
prescriptions to all personnel (military and dependents)
eligible for care in military medical treatment facilities
from 2007 to 2011 [15–17] and we have described the
overall temporal trends in DS prescriptions filled by SMs
from 2005 to 2013 [18]. In this paper, we describe
temporal trends in DS prescriptions in relation to spe-
cific demographic characteristics including military
service, sex, and age.
Methods
This was a descriptive study designed to identify demo-
graphic factors associated with patterns of oral DS pre-
scriptions filled by US military SMs from 2005 through
2013. SMs included the entire population of active duty
personnel in the Army, Navy, Marine Corps, Air Force,
and Coast Guard. DSs were defined based on the Dietary
Supplement Health and Education Act of 1994 as “…a
product (other than tobacco) intended to supplement
the diet that bears or contains one or more of the
following dietary ingredients: a) a vitamin; b) a mineral;
c) an herb or other botanical; d) an amino acid; e) a diet-
ary substance for use by man to supplement the diet by
increasing total dietary intake; or f ) a concentrate,
metabolite, constituent, extract or combination of any
ingredient in clause a to e” [1]. The study was approved
by the Institutional Review Board of the US Army
Research Institute of Environmental Medicine.
To identify DSs available for prescription to SMs two da-
tabases were queried: the Food and Drug Administration
National Drug Code (NDC) database [19] and the US
Defense Health Agency’s Pharmacoeconomic Center
(PEC) database [20]. The NDC database was obtained in
November 2013 and contained 65,536 listed substances.
For the PEC database, the basic and extended core formu-
laries were examined using the search engine at the PEC
website [20]. The following search terms were used to
identify substances classified by First Data Bank as Generic
Class 3 (GC3) categories of drugs which could also be
DSs: vitamins, minerals, protein and amino acids, herbs
and botanical ingredients, fish oil, creatine, joint support,
digestive, and DSs. The GC3 system utilizes 3 characters
(alpha, numeric, and alpha) to represent the organ system,
pharmacological class, and specific therapeutic class. A
total of 34,901 listed substances were identified and the
corresponding NDC numbers, GC3 numbers, and generic
names were provided by a pharmacist from the Defense
Health Agency Pharmacy Operations Division. Two inves-
tigators independently examined the two databases to
identify DSs and subsequently met to resolve any discrep-
ancies. Only substances listed as orally consumed were
considered and all substances listed as “unapproved ho-
meopathics” were excluded. After eliminating overlapping
substances in the two databases, the process resulted in
the identification of 25,291 unique oral DS substances with
distinctive NDCs and GC3s codes (A1B, B3K, C1B,
C1D, C1F, C1H, C1P, C1W, C3B, C3C, C3M, C5B,
C5F, C5G, C5H, C5U, C6A, C6B, C6C, C6D, C6E,
C6F, C6G, C6H, C6I, C6L, C6M, C6N, C6P, C6Q,
C6R, C6T, C6Z, C8E, D4B, D4N, D6S, E0A, E0G,
M4B, M4O, P4D, U5B, U6W, and Z1E).
Once DSs were identified, data were extracted from
PDTS records. NDCs were used as the unit of identifica-
tion to obtain substances dispensed to a SM between
2005 through 2013. The PDTS database was queried to
obtain the number of SMs filling one or more prescrip-
tions. Because of the large number of NDCs, the list was
further reduced by grouping the NDC codes according
to their generic names, as listed in the database (e.g.,
aluminum hydroxide, cholecalciferol, arginine, calcium,
psyllium). In 53 cases there were no generic names listed
but 48 of these records were some form of Vitamin E
and so these were given this generic name. The other 5
substances were not prescribed in the period examined.
Using generic names resulted in 1,711 categories. Of the
1,711 generic categories, 488 had at least one SM receiv-
ing a prescription in the study period. For each of the
488 generic categories, data were obtained from the
PDTS on the military service, sex, and age of SM who
obtained the DS prescriptions.
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A pharmacist placed the 488 generic substances
into the American Hospital Formulary System (AHFS)
Pharmacologic-Therapeutic classifications [21]. After
this, 5 AHFS Pharmacologic-Therapeutic classifications
were combined because they were: 1) subcategories of
higher tier AHFS codes; 2) had a small number of pre-
scriptions in the particular therapeutic classes; and/or 3)
had very similar therapeutic classifications. One group of
pharmacologic-therapeutic classifications that was com-
bined were 28:20.00 (Anorexigenic Agents and Respira-
tory and Cerebral Simulants), 28:20.32 (Respiratory and
Central Nervous System Stimulants), and 28:20.92
(Anorexigenic Agents and Stimulants, Miscellaneous).
The other pharmacologic-therapeutic classifications that
were combined were 92:00.00 (Miscellaneous Therapeutic
Agents) and 92:92.00 (Other Miscellaneous Therapeutic
Agents).
Prevalence of prescriptions filled for various AHFS
categories was calculated as: ∑ of SMs filling one or
more prescription in a particular year divided by ∑ of
SMs for the year times 1,000 (SMs with one or more
prescriptions/1,000 SMs). The Armed Forces Health
Surveillance Branch of the Defense Health Agency pro-
vided denominators (∑ SMs for each year) for each
demographic factor (military service, sex, and age). To
examine trends, data were graphed by year for each
AHFS category and demographic factor. Descriptive
statistics were not necessary for DS data since the data
included all SMs and the point values on the graphs
represent population values (i.e., values are not from a
sample for which statistics would be required).
Results
Table 1 presents the number of SMs filling one or more
oral DS prescriptions by AHFS category and demographics.
During the 9-year surveillance period, 1,448,750 SMs filled
prescriptions, a mean ± standard deviation of 160,972 ±
5,128 SMs per year. The mean ± standard deviation yearly
number of SMs was 1,427,080 ± 22,139 so that 11.3%
(160,972/1,427,080) of all SMs filled an oral DS pre-
scription each year during the study period. Five AHFS
pharmacologic-therapeutic categories accounted for
<0.2% of all individuals filling prescriptions and were
not considered further. These were 1) anorexigenic, re-
spiratory, and central nervous system stimulants; 2)
caloric agents; 3) gastrointestinal drugs; 4) Vitamin A;
and 5) therapeutic agents.
Temporal changes by military service
Figures 1, 2 and 3 present DS prevalence by AHFS
categories, year, and military service. Prevalence for all
prescribed DSs (Fig. 1a) increased over time for Army
and Air Force personnel, while for Marine Corps
personnel prevalence declined by about half between
2006 and 2009. For multivitamin preparations (Fig. 1b)
the Army and Navy showed very slight declines over
time and after 2011, prevalence for the Air Force rose
while that of the Coast Guard declined. Iron preparation
prevalence (Fig. 2a) was much lower for Coast Guard
and Marine personnel than for the other services but all
services showed little change over time. For replacement
preparations (Fig. 2b), Marine Corps personnel demon-
strated a 7.5-fold decline in prevalence from 2007 to
2009 while Army, Navy, and to a lesser extent, Air Force
personnel showed an increase between 2006 and 2009–
2010. Antacid/absorbent prevalence (Fig. 2c) generally
declined in all military services over the study period,
with the largest being a 4-fold decline among Navy
personnel between 2006 and 2008. Prevalence of cathar-
tic/laxative prescriptions (Fig. 2d) generally declined in
most services in 2009, but rose to earlier levels by 2012
in all services except the Air Force.
Vitamin B and B complex (Fig. 3a) prevalence gener-
ally declined for all military services over the study
period. Vitamin C prevalence (Fig. 3b) was highest for
Army and Navy personnel and all services except the
Marine Corps showed increased prevalence during the
study period. Vitamin D prevalence (Fig. 3c) increased in
all services, while Vitamin E prevalence (Fig. 3d) de-
clined in all services during the study period.
Temporal changes by sex
Figures 4, 5 and 6 show DS prevalence by AHFS cat-
egories, year, and sex. Overall prescription prevalence
(Fig. 4a) was about 10 times higher among women com-
pared to men but there was little change over the study
period for either sex. Multivitamin preparations also
changed little over time (Fig. 4b) and prevalence was
over 50 times higher among women. Prenatal vitamins
accounted for 87% of all multivitamin prescriptions. If
prenatal vitamins were not included, multivitamin preva-
lence was 3.1 times higher among women (10.8 vs. 3.5
SMs/1000 SMs for entire study period). For iron prepa-
rations (Fig. 5a), women had about 30 to over 50 times
the prevalence of men (depending on year). There was
little change over time in iron preparation prevalence for
men, but women showed a decline (78 to 65 SMs/1000
SMs) over the study period. Replacement preparation
prevalence (Fig. 5b) changed little among men but
women showed an increase in prevalence in the 2006 to
2009 period followed by a decline. Antacid/absorbent
prevalence declined throughout the study period for
women and men also showed a very slight decline
(Fig. 5c). Cathartics/laxative prevalence declined after
2008 returning to near 2005 levels by 2012 among men
but not women (Fig. 5d).
For the AHFS categories involving vitamins (Fig. 6),
trends were similar for men and women with higher
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prevalence among women for all AHFS categories.
Vitamin B/B Complex (Fig. 6a) and Vitamin E (Fig. 6d)
prevalence declined, while Vitamin C (Fig. 6b) and
Vitamin D (Fig. 6c) prevalence generally increased.
Temporal changes by age
Figures 7, 8 and 9 present DS prevalence by AHFS
categories, year, and age. For all prescriptions (Fig. 7a),
the highest prevalence was for the oldest age group
(≥45 years). For multivitamin preparations (Fig. 7b) the
two youngest age groups had the highest prevalence,
almost 2-fold higher that the two older age groups. How-
ever, when only non-prenatal vitamins were considered, the
prevalence for the entire study period was 4.7, 3.4, 5.0, and
13.7 SMs/1000 SMs for the <25, 25–34, 35–44 and ≥45 year
olds, respectively, with very little change in prevalence over
the time period (yearly data not shown).
For iron preparations (Fig. 8a), all age groups except
the youngest demonstrated an increase in prevalence in
the 2008 to 2009 period with only minor changes after
this. Prescriptions filled for replacement preparations
(Fig. 8b) generally increased in prevalence over the
period with the highest prevalence in the oldest age
group. Antacids/absorbents (Fig. 8c) showed a steady
decrease in prevalence over the study period for all age
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Fig. 2 Prevalence of Prescriptions Filled for Iron Preparations (a), Replacement Preparations (b), Antacids/Absorbents (c) and Cathartics/Laxatives
(d) by Military Service, 2005–2013
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youngest and oldest age groups throughout the period.
There was little change in the prevalence of cathartic/
laxatives (Fig. 8d) for the two youngest age groups but
the two older age groups showed declines from 2008 to
2010 with much larger declines in the oldest age group.
Psyllium and sodium/potassium compounds accounted
for 73% of cathartic/laxative prescriptions for those
≥45 year olds. The trends in prescriptions filled for
cathartic/laxatives in the two older age groups were pri-
marily due to temporal declines in the prevalence of
sodium/potassium compounds with little change in psyl-
lium. In those >45 years of age, the prevalence of
sodium/potassium compounds declined from 59 SMs/
1000 in 2008 to 5 SMs/1000 in 2010.
Vitamin B and B Complex prevalence (Fig. 9a)
declined for all age groups during the study period.
Vitamin C prevalence (Fig. 9b) increased for all age
groups between 2005 and 2007–2009 and showed only
minor changes after that. Vitamin D prevalence (Fig. 9c)
rose in all age groups over the surveillance period while
Vitamin E prevalence (Fig. 9d) decreased in all age
groups. For VitaminB/B Complex, Vitamin D and


















































































































































A – All Prescriptions B - Multivitamin Preparations
Fig. 4 Prevalence of Prescriptions Filled for All Prescriptions (a) and Multivitamin Preparations (b) by Sex, 2005–2013
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Replacement preparations and Vitamin B and B complex
Further examination of replacement preparations showed
that most prescriptions were for calcium salts (74%) and
zinc preparations (12%). For calcium salts (Fig. 10a
through 10c), the largest changes in prevalence occurred
primarily in the Navy and Army, among women, and
among those in the youngest and oldest age groups. For
zinc preparations, the temporal prevalence declines were
primarily among the youngest (<25 year) male Marines
(Fig. 10d through 10f).
For Vitamin B and B Complex, most prescriptions
were for pyridoxine (62%) and folate (27%). During the
study period, pyridoxine showed prevalence declines for
all military services, in both men and women, and for all
age groups (Fig. 11a through 11c). For folate, there were
prevalence declines in all services over the survey period
expect the Marines. These declines were larger for
women and those in the oldest age group (Fig. 11d
through 11f ).
Discussion
This is the first investigation to describe, based directly
on pharmacy records, demographic factors associated



















































































C – Antacids/Absorbents D – Cathartics/Laxatives
Fig. 5 Prevalence of Prescriptions Filled for Iron Preparations (a), Replacement Preparations (b), Antacids/Absorbents (c) and Cathartics/Laxatives





















































































Fig. 6 Prevalence of Prescriptions Filled for Vitamin B and B Complex (a), Vitamin C (b), Vitamin D (c), and Vitamin E (d) by Sex, 2005–2013
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prescriptions filled by the entire population of SMs. The
most notable findings were 1) a generally greater preva-
lence of prescriptions filled by the oldest (>45 years)
SMs for many AHFS categories; 2) greater prevalence of
prescriptions filled by women for all AHFS categories; 3)
a temporal decline in total prescriptions filled by Marine
Corps personnel, accounted for largely by a decline in
the prevalence of zinc preparations by younger male
Marines; 4) a temporal decline in the prevalence of iron
preparations filled by women; 5) a temporal increase in the
prevalence of prescriptions for replacement preparations
filled by women accounted for largely by calcium com-
pounds; and 6) a temporal decline in the prevalence of pre-
scriptions for cathartics/laxatives in the oldest age group
(>45 years) accounted for largely by sodium/potassium
compounds. Other temporal trends seen across virtu-
ally all demographic categories included: 1) a decline in
the prevalence of prescriptions filled for antacids/absor-
bents; 2) a decline in prevalence of prescriptions filled
for Vitamin B and B Complex, accounted largely by a
decline in pyridoxine (Vitamin B6) prescriptions; 3) a
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Fig. 8 Prevalence of Prescriptions Filled for Iron Preparations (a), Replacement Preparations (b), Antacids/Absorbents (c) and Cathartics/Laxatives
(d) by Age, 2005–2013
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Vitamin E; and 4) an increase in the prevalence of pre-
scriptions filled for Vitamin D.
The generally greater prevalence of filled prescriptions
for many AHFS categories among the oldest SMs may
be due to greater health care demands of these individ-
uals. For most major diagnostic categories, ambulatory
visits are greater among older SMs compared to younger
ones [22]. This could lead to a greater number of
prescriptions for treatment of specific medical condi-
tions. In the civilian population, individuals with medical
conditions are more likely to use DSs [12]. In the
present study, women were also much more likely to fill
prescriptions for all categories of DSs than men even
after eliminating prenatal vitamins. In both military and
civilian samples, women are more likely to consume
over-the-counter DSs compared to their male peers
([8, 11, 23] Kennedy, 2013 #4478). Sex differences
may be associated with psychosocial factors relating to
greater health awareness in women. Numerous studies




































































































































D- Zinc  Preparations by Service

































C – Calcium Salts by Age F – Zinc Preparations by Age 
Fig. 10 Prevalence of Prescriptions Filled for Calcium Salts by Military Service (a), Sex (b), and Age (c); Prevalence of Prescriptions Filled for Zinc
Preparations by Military Service (d), Sex (e) and Age (f), 2005–2013
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active consumers of medical care [24–26] and are gener-
ally more likely to make lifestyle changes in an effort to
improve their health [27, 28].
Another study [16] noted a dramatic decline in the use
of zinc preparations among male users of military phar-
macies over a 5-year period from 2007 to 2011. That
study [16] combined active duty Navy and Marine Corps
personnel as well as Navy and Marine dependents for
the purposes of analysis. The present study found the
decline occurred primarily in young, active duty Marine
Corps personnel, with Navy personnel showing little
change. The reason for the high use and decline from
2007–2009 among young Marine Corps personnel is not
clear but one possible reason may relate to findings from
early studies suggesting that zinc preparations may re-
duce the symptoms and duration of acute respiratory ill-
ness [29] and the lack of an adenovirus vaccine in the
1999 to 2011 period [30]. Adenovirus is an infectious
disease and a frequent cause of upper respiratory disease
and pneumonia in military recruits and deployed SMs
[30, 31]. A vaccine for this disease was developed in
1971 and was routinely administered to all military
trainees. However, the manufacturer ceased production
of the vaccine in 1996 and by 1999 adenovirus vaccine
stores were exhausted [32]. A new manufacturer began
producing the vaccine and by 2011 it was reintroduced
into military training centers [32, 33]. There is strong
evidence acute respiratory illnesses increased when the
vaccine was not available and sharply decreased after it
was reintroduced [33]. Zinc preparations may have been
provided to Marine Corps recruits and others because
prior to 2008 evidence suggested zinc preparations could
reduce the duration and symptoms of respiratory ill-
nesses [29]. However, shortly after 2007 studies were
published indicating they may not be effective [34]. A
Cochrane review of 18 trials indicated that oral zinc ad-
ministered within 24 h of symptom onset may slightly
shorten the duration of the respiratory illness in
healthy people. The review found no association be-
tween oral zinc supplements and symptom severity,
and the prevalence of minor adverse effects with zinc
lozenges was high [35].
Compared to men, the markedly higher prevalence of
iron prescriptions filled by women (30 to over 50 times
higher) may be associated with the higher level of iron
deficiency among women. Iron deficiency is defined as a
serum ferritin of <15 μg/l. Using this criteria, the
National Health and Nutrition Examination Survey
found that about 14% of women and <1% of men were
iron deficient [36], and this may have led to medical care
providers offering, or women requesting, more iron-
related prescriptions. Of importance for the military,
studies have shown that iron supplementation can
generally improve the aerobic capacity and physical per-
formance among women of reproductive age, especially
those that are iron deficient [37, 38].
There was a 17% decline (78 to 65 SMs/1000) in iron
preparation prevalence among women during the study
period. Routine iron supplementation is often recom-

















































































A – Pyridoxine (B6) by Military Service
B – Pyridoxine (B6) by Sex E – Folate (B9) by Sex
C – Pyridoxine (B
6
) by Age F – Folate (B9) by Age 
Fig. 11 Prevalence of Prescriptions Filled for Pyridoxine (Vitamin B6) by Military Service (a), Sex (b), and Age (c); Prevalence of Prescriptions filled
for Folate (Vitamin B9) by Military Service (d), Sex (e) and Age (f), 2005–2013
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1990’s differing opinions were published by several na-
tional organizations regarding the validity of this recom-
mendation [40]. During the study period, studies,
reviews, and editorials were published with conflicting
information on the effectiveness of, and need for, iron
supplementation among pregnant women [41–44] that
may have led to some confusion among providers. The
latest review for the US Preventive Services Task Force
concluded that even for iron deficient women, the evi-
dence is still inconclusive as to whether or not routine
iron supplementation improves maternal or infant health
outcomes, although it does appear to improve maternal
hematological indices [45]. The birth rate in military
women was relatively consistent in the 2005 to 2012
period [46, 47] so it is unlikely that reduced fertility (i.e.,
a reduction in the number of women who might be
recommended iron supplementation during preg-
nancy) could account for the decline in iron prepar-
ation prescriptions. It is not clear what may account
for the decline in iron preparations among women
during the study period.
Another interesting observation was the temporal in-
crease (followed by a decrease) in the prevalence of pre-
scriptions filled by women for replacement preparations.
Replacement preparations are a very broad category of
substances designed to treat a variety of specific nutri-
tional deficiencies. In the present study, 74% of replace-
ment preparations involved calcium salts and of these,
64% were combined with some form of Vitamin D.
Studies conducted shortly before or during the study
period indicated that either the dietary intake of Vitamin
D or the plasma level of 25-hydroxyvitamin D (25(OH)D)
(the accepted clinical indicator of Vitamin D status) of
Americans was insufficient [48–50]. Considerable attention
was given to this fact in both the popular press [51–53]
and in scientific/medical journals [54–56]. This informa-
tion, combined with more accurate methods of measuring
25(OH)D [57] led to an increase in the recommended daily
allowance of Vitamin D and calcium [58]. This may at least
partly account for the increase over the study period in
prescriptions filled for calcium salt preparations, especially
those containing Vitamin D.
The decreasing temporal trend in cathartics/laxatives
in those >44 years of age was accounted for largely by a
decline in prescriptions filled for sodium/potassium
compounds. In the 1990’s and into the 2000’s there were
a number of case reports on patients who developed
acute renal failure after the use of sodium/potassium
compounds as a cathartic agent [59–61]. This was
followed in 2005 by a case series of acute renal failure in
21 patients using these compounds over a 5 year period
[62]. In December 2008 the US FDA issued a safety alert
that documented 20 cases of kidney injury reported to
the FDA and required new safety measures for drugs of
this type [63]. The rapid decline in use by older SMs
may have been associated with the potential for kidney
injuries, the FDA warning, and the availability of other
substances that could be used as cathartic agents.
Certain trends were seen across virtually all demo-
graphic categories and we attempted to explain these in
our previous paper [18]. The decline in the prevalence of
antacids/absorbents was likely due to the development
and use of advanced drugs like proton pump inhibitors,
potassium–competitive acid blockers and other drugs for
treating gastroesophageal reflux disease that reduced the
need for antacids/absorbents [64, 65]. The increases in
Vitamin D prevalence was discussed above and was likely
associated with better availability and more accurate assay
procedures for determining 25-OH-D [57], knowledge
that large portions of individuals may be Vitamin D defi-
cient [48–50], and changes in national policy increasing
the recommended daily allowance of Vitamin D [58]. De-
clines in the prevalence of Vitamin E may be associated
with studies suggesting that high-dose Vitamin E increases
mortality [66–68], results of large randomized prospective
cohort trials suggesting few benefits for treating specific
diseases [69–71], and recommendations of the US Pre-
ventive Services Task Force against the use of Vitamin E
for primary prevention of specific diseases [72, 73]. The
decline in B Complex Vitamin prevalence was accounted
largely by a decline in pyridoxine (Vitamin B6) prevalence,
and to a much lesser extent by the decline in folate
(Vitamin B9) prevalence. Although pyridoxine had been
suggested for the treatment of carpel tunnel syndrome,
hyperhomocystemia, and other conditions [74–79], stud-
ies conducted over the study period generally did not
support these uses [80–82], thereby possibly accounting
for the decline in prevalence.
Conclusions
Our previous work [18] described overall trends in pre-
scribed oral DSs filled by all military SMs from 2005 to
2013. In the present paper, we examined patterns of DS
prescriptions that were filled by specific demographic
groups. Age, sex, and service-specific factors assisted in
interpreting some temporal trends, while others were in-
dependent of these factors and seen across all demo-
graphic groups examined. The perceptions and knowledge
of providers and patients appeared to be important for in-
terpretation of trends in prescriptions and will continue to
evolve as new knowledge emerges. Continuing surveil-
lance of prescribed DSs will identify if the demographic
trends observed here continue or if new patterns emerge.
Abbreviations
AHFS: American hospital formulary system; DS: Dietary supplement;
GC3: Generic Class 3; NDC: National drug code; PDTS: Pharmacy data
transaction system; PEC: Pharmacoeconomic center; SM: Service member;
US: United States.
Knapik et al. BMC Complementary and Alternative Medicine  (2017) 17:84 Page 11 of 14
Acknowledgements
We would like to thank Dr Angie Cost from the Armed Forces Health
Surveillance Branch of the Defense Health Agency for providing
denominators that allowed calculation of prevalence.
Funding
This research was supported in part by an appointment to the Knowledge
Preservation Program at the US Army Research Institute of Environmental
Medicine (USARIEM) and the Army Public Health Center (APHC) administered
by the Oak Ridge Institute for Science and Education through an interagency
agreement between the U.S. Department of Energy and USARIEM and APHC.
Funding was also provided by the Center Alliance for Nutrition and Dietary
Supplement Research.
Availability of data and materials
Datasets analyzed during the current study available from the corresponding
author on reasonable request.
Authors' contributions
JJK compiled the DSs, performed the statistical analysis, interpreted the data,
and prepared the manuscript. RT compiled the pharmacy data, interpreted
the data, and assisted in manuscript preparation. KGA compiled the DSs,
interpreted the data, and assisted in manuscript preparation. RAS assisted in
determining the DSs, interpreted the data, and assisted in manuscript
preparation. EKF interpreted the data and assisted in manuscript preparation.
HRL assisted in determining the DSs examined, interpreted the data, and
assisted in manuscript preparation. All authors read, commented on, and
approved the final manuscript.
Authors' information
The views, opinions, and findings in this report are those of the authors and
should not be construed as an official Department of Defense or Army position,
policy, or decision, unless so designated by other official documentation.
Citations of commercial organizations and trade names in this report do not
constitute an official Department of the Army endorsement or approval of the
products or services of these organizations. The investigators have adhered to
the policies for protection of human subjects as prescribed in DOD Instruction
3216.02 and the research was conducted in adherence with the provisions of
32 CFR Part 219.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable
Ethics approval and consent to participate
The study was approved by the Institutional Review Board of the US Army
Research Institute of Environmental Medicine and a waiver of informed
consent was granted.
Author details
1US Army Research Institute of Environmental Medicine, Natick, MA, USA. 2US
Army Public Health Center, Aberdeen Proving Ground, MD, USA. 3Oak Ridge
Institute for Science and Education, Belcamp, MD, USA. 4Office of The US
Army Surgeon’s General Pharmacovigilance Center, Falls Church, VA, USA.
5Defense Health Agency, Falls Church, VA, USA. 6Research Physiologist,
(USARIEM), 10 General Greene Ave, Natick, MA 01760, USA.
Received: 10 October 2016 Accepted: 17 January 2017
References
1. Strengthening knowledge and understanding of dietary supplements.
http://ods.od.nih.gov/About/DSHEA_Wording.aspx. Accessed 4 Feburary
2013.
2. Dickinson A, Boyon N, Shao A. Physician and nurses use and recommend
dietary supplements: report of a survey. Nutr J. 2009;8:29.
3. Dickinson A, Bonci L, Boyon N, Franco JC. Dietitians use and recommend
dietary supplements: report of a survey. Nutr J. 2012;11:14.
4. Koplan JP, Annest JL, Layde PM, Rubin GL. Nutrient intake and supplementation
in the United States (NHANES II). Am J Public Health. 1986;76(3):287–9.
5. Balluz LS, Kieszak SM, Philen RM, Mulinare J. Vitamin and mineral
supplement use in the United States. Arch Fam Med. 2000;9:258–62.
6. Radimer K, Bindewald B, Hughes J, Ervin B, Swanson C, Picciano MF. Dietary
supplement use by US adults: data from the National Health and Nutrition
Examination Survey, 1999–2000. Am J Epidemiol. 2004;160(4):339–49.
7. Kennedy ET, Luo H, Houser RF. Dietary supplement use pattern of US adult
population in the 2007–2008 National Health and Nutrition Survey
(NHANES). Ecol Food Nutr. 2013;52:76–84.
8. Knapik JJ, Steelman R, Hoedebecke S, Farina E, Austin K, Lieberman HR. A
systematic review and meta-analysis on the prevalence of dietary supplement
use by military personnel. BMC Complement Altern Med. 2014;14:143.
9. Austin KG, Price LL, McGraw SM, Lieberman HR. Predictors of dietary
supplement use by US Coast Guard personnel. PLOS One. 2015;10(7):e133006.
10. Austin KG, Price LL, Mcgraw SM, Leahy G, Lieberman HR. Demographic,
lifestyle factors and reasons for use of dietary supplements by Air Force
personnel. Aerosp Med Med Hum Perform. 2016;87(7):628–37.
11. Knapik JJ, Trone DW, Austin KG, Steelman RA, Farina EK, Lieberman HR.
Prevalence, adverse effects, and factors associated with dietary supplement
and nutritional supplement use by United States Navy and Marine Corps
personnel. J Acad Nutr Diet. 2016;116(9):1423–42.
12. Farina EK, Austin KG, Lieberman HR. Concomitant dietary supplement and
prescription medication use is prevalent among US adults with doctor-
informed medical conditions. J Acad Nutr Diet. 2014;114(11):1784–90.
13. Eisenberg DM, Davis RB, Ettner SL, Appel S, Wilkey S, Rompay MV, Kessler
RC. Trends in alternative medicine use in the United States, 1990–1997.
JAMA. 1998;280(18):1569–75.
14. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA. Recent
patterns of medication use in the ambulatory adult population of the
United States. JAMA. 2002;297(3):337–44.
15. Krieger JA, Arnold RM, Attipoe S, Jones DR, Stephens MB, Deuster PA.
Trends in B-Vitamin prescriptions from military treatment facilities: 2007–
2011. Mil Med. 2015;180:732–6.
16. Attipoe S, Jones DR, Olsen CH, Stephens MB, Deuster PA. Trends in mineral
supplement prescriptions from military treatment facilities: 2007–2011. Mil
Med. 2015;180:742–7.
17. Morioka TY, Bolin JT, Attipoe S, Jones DR, Stephens MB, Duester PA. Trends
in Vitamin A, C, D, E, K Supplement Prescriptions from military treatment
facilities: 2007 to 2011. Mil Med. 2015;180:748–53.
18. Knapik JJ, Thelus R, Austin KG, Steelman RA, Gannon J, Farina EK, Lieberman
HR. Prevalence and temporal trends in dietary supplement prescriptions
filled by United States military service members suggest a decrease in
pyridoxine and increase in vitamin D supplements from 2005–2013. Nutr
Res. 2016;36(10):1140–52.
19. US Food and Drug Administration National Drug Code Directory. http://
www.fda.gov/Drugs/InformationOnDrugs/ucm142438.htm. Accessed 13
November 2013
20. The Defense Health Agency Pharmacy Operations Division TRICARE Formulary
Search Tool. http://vce.health.mil/MHSHome/About-MHS/Defense-Health-
Agency/Operations/Pharmacy-Division. Accessed 18 Jan 2017.
21. American Hospital Formulary Hospital System Drug Information. Bethesda
MD: American Society of Health-System Pharmacists; 2013.
22. Ambulatory visits among members of the active component, US Armed
Forces, 2015. MSMR. 2016;23(4):17–25.
23. Millen AE, Dodd KW, Subar AF. Use of vitamin, mineral nonvitamin and
nonmineral supplements in the United States: the 1987, 1992 and 2000
National Health Interview Survey results. J Am Diet Assoc. 2004;104:942–50.
24. Owens GM. Gender differences in health care expenditures, resource
utilization, and quality of care. J Manag Care Pharm. 2008;14(3 Suppl):S2–6.
25. Muller C. Review of twenty years of research on medical care utilization.
Health Serv Res. 1986;21(2):129–43.
26. Ladwig KH, Marten-Mittag B, Formanek B, Dammann G. Gender differences
in symptom reporting and medical care utilization in the German
population. Eur J Epidemiol. 2000;16:511–8.
27. Patterson RE, Neuhouser ML, Hedderson MM, Schwartz SM, Standish LJ,
Bowen DJ. Changes in diet, physical activity, and supplement use among
adults diagnosed with cancer. J Am Diet Assoc. 2003;103:323–8.
28. Assaf AR, Parker D, Lapane KL, Coccio E, Evangelou E, Carleton RA. Does the
Y chromosome make a difference? Cardiovascular disease risk factors.
J Women's Health. 2003;12(4):321–30.
Knapik et al. BMC Complementary and Alternative Medicine  (2017) 17:84 Page 12 of 14
29. Garland ML, Hagmeyer KO. The role of zinc lozenges in the treatment of
the common cold. Ann Pharmacother. 1998;32(1):63–9.
30. Gray GC, Goswami PR, Malasig MD, Hawksworth AW, Trump DH, Ryan MA,
Schnurr DP. Adult adenovirus infections: loss of orphaned vaccines precipitates
military respiratory disease epidemics. Clin Infect Dis. 2000;31:633–70.
31. Sanford JP. Acute respiratory disease in the United states Army in the
Republic of Vietnam, 1965–1970. Yale J Biol Med. 1975;48(3):179–84.
32. Hoke CH, Hawksworth A, Snyder CE. Initial assessment of the impact of
adenovirus Type 4 and type 7 vaccine on febrile respiratory illness and
virus transmission in miltary basic trainees, March 2012. MSMR. 2012;
19(3):2–5.
33. Incidence of acute respiratory illness among enlisted service members
during their first year of military service: did the 2011 resumption of
adenovirus vaccination of basic trainees have an effect? MSMR. 2013;
20(5):14–8.
34. Caruso TJ, Prober CG, Gwaltney JM. Treatment of naturally acquired common
colds with zinc: a structured review. Clin Infect Dis. 2007;45:569–74.
35. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev.
2013;6:CD001364.
36. Second national report on biochemical indicators of diet and nutrition
in the U.S. population. http://www.cdc.gov/nutritionreport. Accessed 19
July 2016.
37. Pasricha SR, Low M, Thompson J, Farrell A, DeRegil LM. Iron
supplementation benefits physical performance in women of reproductive
age: systematic review and meta-analysis. J Nut. 2014;144:906–14.
38. McClung JP, Karl JP, Cable SJ, Williams KW, Nindl BC, Young AJ,
Liberman HR. Randomized, double-blind, placebo controlled trial of iron
supplementation in female soldiers during military training: effects on
iron status, physical performance, and mood. Am J Clin Nutr. 2009;90:
124–31.
39. McDonagh M, Cantor A, Bougatsos C, Dana T, Blazina I. Routine iron
supplementation and screening for iron deficiency anemia in pregnant
women: a systematic review to update the US Preventive Services Task
Force recommendation. Evidence synthesis No 123. Rockville: Agency for
Health Care Research and Quality; 2015.
40. Recommendations to prevent and control iron deficiency in the United
States. MMWR. 1998;47(RR-3):1–36.
41. Haram K, Nilsen ST, Ulvik RJ. Iron supplementation in pregnancy - evidence
and controversies. Acta Obstetricia et Gynecologica Scandinavica. 2001;
80(8):683–8.
42. Haider BA, Olofin I, Wang M, Spiegelman D, Ezzati D, Fawzi WW. Anaemia,
prenatal iron use and the risk of adverse pregnancy outcomes: sysyematic
review and meta-analysis. Br Med J. 2013;346:f3443.
43. Steer PJ. Healthy pregnant women still don't need routine iron
supplementation. Br Med J. 2013;347:f4866.
44. Tiwari AK, Mahdi MA, Chandyan S, Zahra F, Godbole MM, Jaiswar SP, Srivastava
VK, Negi MP. Oral iron supplementation leads to oxidative imbalance in
anemic women: a prospective study. Clin Nutr. 2011;30(2):188–93.
45. Cantor AG, Bougatsos C, Dana T, Blazina L, McDonagh M. Routine iron
supplementation and screening for iron deficiency anemia in pregnancy: a
systematic review for the US Preventive Services Task Force. Ann Int Med.
2015;162(8):566–76.
46. Births, active component, U.S. Armed Forces, 2001–2010. MSMR. 2011;18(12):
16–7.
47. Surveillance snapshot: births, active component service women, US Armed
Forces, 2001–2012. MSMR. 2013;20(9):28.
48. Calvo MS, Whiting SJ. Prevalence of Vitamin D insufficiency in Canada and
the United States: importance to health status and efficacy of current food
fortification and dietary supplement use. Nutr Rev. 2003;61(3):107–13.
49. Moore C, Murphy MM, Keast DA, Holick MF. Vitamin D intake in the United
States. J Am Diet Assoc. 2004;104(6):980–3.
50. Nesby-O'Dell S, Scanlon KS, Cogswell ME, Gillespie C, Hollis BW, Looker AC,
Allen C, Dougherly C, Gunter EW, Bowman BA. Hypovitaminosis D
prevalence and determinates among African American and white women
of reproductive age: the National Health and Nutrition Examination Survey,
1988–1994. Am J Clin Nutr. 2002;76:187–92.
51. Brody JE. What do you lack? Probably Vitamin D. New York Times 2010, July 26.
52. Nagourney E. Nutrition: shortage of Vitamin D may weaken the elderly. New
York Times. 2007;1:12.
53. Johnson TD. Guarding against the dangers of Vitamin D deficiency. Life
Extension Magazine. 2007. p. 15–21.
54. Vitamin D deficiency soars in the US study says http://www.
scientificamerican.com/article/vitamin-d-deficiency-united-states/.
Accessed 5 August 2014
55. Bordelon P, Ghetu MV, Langan R. Recognition and management of Vitamin
D deficiency. Am Fam Physician. 2009;80(8):841–6.
56. Holick MF. Vitamin D deficiency. New Engl J Med. 2007;357:266–81.
57. Edlich RF, Mason SS, Reddig JS, Gubler K, Long WB. Revolutionary advances
in the diagnosis of Vitamin D deficiency. J Environ Pathol Toxicol Oncol.
2010;29(2):85–9.
58. Ross AC, Taylor CL, Yaktine AL, DelValle HB (eds). Dietary Reference Intakes
for Calcium and Vitamin D. Washington DC: National Academies Press; 2011.
59. Desmeules S, Bergeron MJ, Isenring P. Acute phosphate nephrophy and
renal failure. New Engl J Med. 2003;349(10):1006–7.
60. Fine A, Patterson J. Severe hyperphosphatemia following phosphate
administration for bowel preparation in patients with renal failure: two
case reports and a review of the literature. Am J Kidney Dis. 1997;29(1):
103–5.
61. Orias M, Mahnensmith RL, Perazella MA. Extreme hyperphosphatemiqa and
acute renal failure after a phosphase- containing boowel regimen.
Am J Nephrol. 1999;19:60–3.
62. Markowitz GS, Stokes MB, Radhakrishnan J, D'Agati VD. Acute phosphate
nephropathy following oral sodium phosphase bowel purgative: an
underrecognized casuse of chronic renal failure. J Am Soc Nephrol. 2005;16:
3389–96.
63. FDA Requires New Safety Measures for Oral Sodium Phosphate
Products to Reduce Risk of Acute Kidney Injury. Risk associated with
both prescription and over-the-counter (OTC) products. http://www.fda.
gov/NewsEvents/Newsroom/PressAnnouncements/2008/ucm116988.htm.
Accessed 25 July 2016.
64. Sachs G, Shin JM, Vagin O, Munson K, Weeks D, Scott DR. Current trends in
the treatment of upper gastrointestinal disease. Best Pract Res Clin
Gastroentrol. 2002;16(6):835–49.
65. Hershcovici T, Fass R. Phramacological management of GRED: where does it
stand now? Trends Pharmacol Sci. 2011;32(4):258–64.
66. Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E.
Meta-analysis: high dosage Vitamin E supplementation may increase all-
cause mortality. Ann Int Med. 2005;142:37–46.
67. Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements
for prevention of gastrointestinal cancers: a systematic review and meta-
analysis. Lancet. 2004;364:1219–28.
68. Hemila H. Vitamin E is likely to affect mortality even at low dose. Clin Trials.
2009;6:392–3.
69. Marchioli R. Antioxidant vitamins and prevention of cardiovascular disease:
laboratory, epidemiological and clinical trial data. Pharmacol Res. 1999;40(3):
227–38.
70. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and
cardiovascular disease. A critical review of epidemiological and clinical trial
data. Ann Int Med. 1995;123:860–72.
71. Clarke MW, Burnett JR, Croft KD. Vitamin E in human health and disease.
Crit Rev Clin Lab Sci. 2008;45(5):417–50.
72. Moyer VA. Vitamin, mineral, and multivitamin supplements for the
primary prevention of cardiovascular disease and cancer: US Preventive
Services Task Force recommendation statement. Ann Int Med. 2014;
160(8):558–65.
73. Fortmann SP, Burda BU, Senger CA, Linn JS, Whitlock EP. Vitamin and
mineral supplements in the primary prevention of cardiovascular disease
and cancer: an updated systematic evidence review for the US Preventive
Services Task Force. Ann Int Med. 2013;159(12):824–34.
74. Vitamin B6 (pyridoxine; pridoxal 5'-phosphate). Altern Med Rev. 2001;6(1):
87–92.
75. Clayton PT. B6-responsive disorders: a model of vitamin dependency.
J Inherited Metab Dis. 2006;29:317–26.
76. Debreceni B, Debreceni L. The role of homocysteine-lowering B-vitamins in the
primary prevention of cardiovascular disease. Cardiovas Ther. 2014;32:130–8.
77. Merrill AH, Henderson JM. Diseases associated with defects in Vitamin B6
metabolism or utilization. Annu Rev Nutr. 1987;7:137–56.
78. Koren G. Treating morning sickness in the United States–changes in
prescribing are needed. Am J Obstet Gynecol. 2014;211(6):602–6.
79. Nausea and vomiting of pregnancy. Obstet Gynecol. 2004;103(4):803–15.
80. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wag H,
Nordrehaug JE, Arnesen E, Rasmussen K. Homocysteine lowering
Knapik et al. BMC Complementary and Alternative Medicine  (2017) 17:84 Page 13 of 14
cardiovascular events after acute myocardial infarction. New Engl J Med.
2006;354:1578–88.
81. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE,
Refsum H, Pedersen EKR, Nygard O. Mortality and cardiovascular events in
patients treated with homosysteine-lowering B vitamins after coronary
angiography. JAMA. 2008;300(7):795–804.
82. Ashworth N: Carpal tunnel syndrome. BMJ Clin Evid 2010:1114.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Knapik et al. BMC Complementary and Alternative Medicine  (2017) 17:84 Page 14 of 14
